PUBLISHER: Persistence Market Research | PRODUCT CODE: 1801286
PUBLISHER: Persistence Market Research | PRODUCT CODE: 1801286
Sublingual Allergy Immunotherapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Persistence Market Research has recently released a comprehensive report on the worldwide market for sublingual allergy immunotherapy. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.
Key Insights:
- Sublingual Allergy Immunotherapy Market Size (2025E): USD 1,092.20 Million
- Projected Market Value (2032F): USD 2,022.40 Million
- Global Market Growth Rate (CAGR 2025 to 2032): 9.2%
Sublingual Allergy Immunotherapy Market - Report Scope:
Sublingual allergy immunotherapy (SLIT) represents a transformative approach to treating allergic conditions, including allergic rhinitis, asthma, and conjunctivitis. SLIT involves the administration of allergen extracts under the tongue, offering a non-invasive and patient-friendly alternative to traditional subcutaneous immunotherapy (SCIT). This treatment modality is gaining widespread acceptance due to its convenience, improved patient adherence, and favorable safety profile. The sublingual allergy immunotherapy market serves a broad spectrum of healthcare providers, including allergy specialists, general practitioners, and pediatricians, across hospital and outpatient settings.
Market Growth Drivers:
The global sublingual allergy immunotherapy market is propelled by several key factors, including the rising prevalence of allergic diseases due to environmental pollution, climate change, and genetic predisposition. Growing awareness about the long-term benefits of immunotherapy in reducing symptoms and medication use has driven both physician and patient preference for SLIT. In addition, regulatory approvals for SLIT tablets targeting specific allergens, such as grass pollen, ragweed, and house dust mites, have expanded treatment options and bolstered market demand. Moreover, a shift towards personalized medicine and improved diagnostic tools has enhanced patient selection and therapy outcomes, accelerating adoption rates worldwide.
Market Restraints:
Despite the market's optimistic outlook, sublingual allergy immunotherapy faces challenges including limited reimbursement coverage in certain regions, particularly in low- and middle-income countries. The high cost of SLIT tablets and extended treatment duration can deter patients from completing therapy. Furthermore, variations in clinical guidelines and allergen standardization across countries hinder the harmonization of treatment protocols. Physician hesitation due to limited familiarity with SLIT in some markets also impacts adoption, highlighting the need for continued education and real-world evidence to reinforce clinical confidence.
Market Opportunities:
The SLIT market presents strong growth opportunities driven by continued product innovation, expanded indications, and increasing investments in allergy research. The development of combination therapies targeting multiple allergens, advancements in recombinant allergen formulations, and the integration of digital health solutions for therapy monitoring open new avenues for market players. Strategic collaborations between pharmaceutical companies, academic institutions, and regulatory bodies are fostering R\&D and expediting product pipelines. Additionally, rising healthcare awareness and improving allergy diagnostics in emerging economies create untapped potential for SLIT expansion.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the sublingual allergy immunotherapy market globally?
- Which allergens and formulations are gaining traction in different regions?
- How are regulatory changes and clinical data shaping the future of SLIT?
- Who are the leading players in the SLIT market, and what strategies are they employing to sustain competitiveness?
- What are the emerging trends and technological innovations influencing market dynamics?
Competitive Intelligence and Business Strategy:
These companies are actively developing new allergen-specific tablets, investing in robust distribution networks, and forging partnerships with healthcare providers and research organizations. Emphasis on patient-centric approaches, such as telehealth integration and mobile adherence tools, enhances engagement and improves outcomes. Additionally, collaboration with payers and regulators to expand reimbursement access remains a pivotal strategy to support long-term market sustainability.
Key Companies Profiled:
- ALK Abello
- Stallergenes Greer
- Allergy Therapeutics
- Aimmune Therapeutics
- Biomay AG
- HAL Allergy group
- DBV Technologies
- Merck KGaA
- WOLWpharma
Sublingual Allergy Immunotherapy Market Research Segmentation:
Drug:
- Odactra
- Grastek
- Ragwitek
- Oralair
- Actair
- Others
Indication:
- Allergic Rhinitis
- Allergic Asthma
- Food Allergy
- Atopic Dermatitis
- Others
Allergen:
- Pollen
- * Grass Pollen
- * Weed Pollen
- * Tree Pollen
- House Dust Mites
- Mold
- Animal Dander
- Bee Venom
- Cockroaches/Insects
- Others
Distribution Channel:
- Institutional Sales
- * Government Hospitals
- * Semi-Government Hospitals
- * Private Hospitals
- Retail Sales
- * Retail Pharmacies
- * Drug Stores
- * Online Pharmacies
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Sublingual Allergy Immunotherapy Market Snapshot 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
- 1.3. Key Market Trends
- 1.4. Industry Developments and Key Market Events
- 1.5. Demand Side and Supply Side Analysis
- 1.6. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definitions
- 2.2. Value Chain Analysis
- 2.3. Macro-Economic Factors
- 2.3.1. Global GDP Outlook
- 2.3.2. Global GDP Outlook
- 2.3.3. Global economic Growth Forecast
- 2.3.4. Global Urbanization Growth
- 2.3.5. Other Macro-economic Factors
- 2.4. Forecast Factors - Relevance and Impact
- 2.5. COVID-19 Impact Assessment
- 2.6. PESTLE Analysis
- 2.7. Porter's Five Forces Analysis
- 2.8. Geopolitical Tensions: Market Impact
- 2.9. Regulatory and Technology Landscape
3. Market Dynamics
- 3.1. Drivers
- 3.2. Restraints
- 3.3. Opportunities
- 3.4. Trends
4. Price Trend Analysis, 2019-2032
- 4.1. Region-wise Price Analysis
- 4.2. Price by Segments
- 4.3. Price Impact Factors
5. Global Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 5.1. Key Highlights
- 5.2. Global Sublingual Allergy Immunotherapy Market Outlook: Drug
- 5.2.1. Introduction/Key Findings
- 5.2.2. Historical Market Size (US$ Mn) Analysis by Drug, 2019-2024
- 5.2.3. Current Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 5.2.3.1. Odactra
- 5.2.3.2. Grastek
- 5.2.3.3. Ragwitek
- 5.2.3.4. Oralair
- 5.2.3.5. Actair
- 5.2.4. Market Attractiveness Analysis: Drug
- 5.3. Global Sublingual Allergy Immunotherapy Market Outlook: Indication
- 5.3.1. Introduction/Key Findings
- 5.3.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2024
- 5.3.3. Current Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 5.3.3.1. Allergic Rhinitis
- 5.3.3.2. Allergic Asthma
- 5.3.3.3. Food Allergy
- 5.3.3.4. Atopic Dermatitis
- 5.3.3.5. Others
- 5.3.4. Market Attractiveness Analysis: Indication
- 5.4. Global Sublingual Allergy Immunotherapy Market Outlook: Allergen
- 5.4.1. Introduction/Key Findings
- 5.4.2. Historical Market Size (US$ Mn) Analysis by Allergen, 2019-2024
- 5.4.3. Current Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 5.4.3.1. Pollen
- 5.4.3.2. House Dust Mites
- 5.4.3.3. Mold
- 5.4.3.4. Animal Dander
- 5.4.3.5. Bee Venom
- 5.4.3.6. Cockroaches/Insects
- 5.4.3.7. Others
- 5.4.4. Market Attractiveness Analysis: Allergen
- 5.5. Global Sublingual Allergy Immunotherapy Market Outlook: Distribution Channel
- 5.5.1. Introduction/Key Findings
- 5.5.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2019-2024
- 5.5.3. Current Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 5.5.3.1. Institutional Sales
- 5.5.3.2. Retail Sales
- 5.5.4. Market Attractiveness Analysis: Distribution Channel
6. Global Sublingual Allergy Immunotherapy Market Outlook: Region
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
- 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia & Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
- 6.4. Market Attractiveness Analysis: Region
7. North America Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 7.1. Key Highlights
- 7.2. Pricing Analysis
- 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
- 7.4. North America Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 7.4.1. Odactra
- 7.4.2. Grastek
- 7.4.3. Ragwitek
- 7.4.4. Oralair
- 7.4.5. Actair
- 7.5. North America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 7.5.1. Allergic Rhinitis
- 7.5.2. Allergic Asthma
- 7.5.3. Food Allergy
- 7.5.4. Atopic Dermatitis
- 7.5.5. Others
- 7.6. North America Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 7.6.1. Pollen
- 7.6.2. House Dust Mites
- 7.6.3. Mold
- 7.6.4. Animal Dander
- 7.6.5. Bee Venom
- 7.6.6. Cockroaches/Insects
- 7.6.7. Others
- 7.7. North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 7.7.1. Institutional Sales
- 7.7.2. Retail Sales
8. Europe Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 8.1. Key Highlights
- 8.2. Pricing Analysis
- 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. Italy
- 8.3.3. France
- 8.3.4. U.K.
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Rest of Europe
- 8.4. Europe Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 8.4.1. Odactra
- 8.4.2. Grastek
- 8.4.3. Ragwitek
- 8.4.4. Oralair
- 8.4.5. Actair
- 8.5. Europe Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 8.5.1. Allergic Rhinitis
- 8.5.2. Allergic Asthma
- 8.5.3. Food Allergy
- 8.5.4. Atopic Dermatitis
- 8.5.5. Others
- 8.6. Europe Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 8.6.1. Pollen
- 8.6.2. House Dust Mites
- 8.6.3. Mold
- 8.6.4. Animal Dander
- 8.6.5. Bee Venom
- 8.6.6. Cockroaches/Insects
- 8.6.7. Others
- 8.7. Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 8.7.1. Institutional Sales
- 8.7.2. Retail Sales
9. East Asia Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 9.1. Key Highlights
- 9.2. Pricing Analysis
- 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
- 9.4. East Asia Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 9.4.1. Odactra
- 9.4.2. Grastek
- 9.4.3. Ragwitek
- 9.4.4. Oralair
- 9.4.5. Actair
- 9.5. East Asia Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 9.5.1. Allergic Rhinitis
- 9.5.2. Allergic Asthma
- 9.5.3. Food Allergy
- 9.5.4. Atopic Dermatitis
- 9.5.5. Others
- 9.6. East Asia Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 9.6.1. Pollen
- 9.6.2. House Dust Mites
- 9.6.3. Mold
- 9.6.4. Animal Dander
- 9.6.5. Bee Venom
- 9.6.6. Cockroaches/Insects
- 9.6.7. Others
- 9.7. East Asia Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 9.7.1. Institutional Sales
- 9.7.2. Retail Sales
10. South Asia & Oceania Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 10.1. Key Highlights
- 10.2. Pricing Analysis
- 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of SAO
- 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 10.4.1. Odactra
- 10.4.2. Grastek
- 10.4.3. Ragwitek
- 10.4.4. Oralair
- 10.4.5. Actair
- 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 10.5.1. Allergic Rhinitis
- 10.5.2. Allergic Asthma
- 10.5.3. Food Allergy
- 10.5.4. Atopic Dermatitis
- 10.5.5. Others
- 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 10.6.1. Pollen
- 10.6.2. House Dust Mites
- 10.6.3. Mold
- 10.6.4. Animal Dander
- 10.6.5. Bee Venom
- 10.6.6. Cockroaches/Insects
- 10.6.7. Others
- 10.7. South Asia & Oceania Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 10.7.1. Institutional Sales
- 10.7.2. Retail Sales
11. Latin America Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 11.1. Key Highlights
- 11.2. Pricing Analysis
- 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of LATAM
- 11.4. Latin America Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 11.4.1. Odactra
- 11.4.2. Grastek
- 11.4.3. Ragwitek
- 11.4.4. Oralair
- 11.4.5. Actair
- 11.5. Latin America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 11.5.1. Allergic Rhinitis
- 11.5.2. Allergic Asthma
- 11.5.3. Food Allergy
- 11.5.4. Atopic Dermatitis
- 11.5.5. Others
- 11.6. Latin America Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 11.6.1. Pollen
- 11.6.2. House Dust Mites
- 11.6.3. Mold
- 11.6.4. Animal Dander
- 11.6.5. Bee Venom
- 11.6.6. Cockroaches/Insects
- 11.6.7. Others
- 11.7. Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 11.7.1. Institutional Sales
- 11.7.2. Retail Sales
12. Middle East & Africa Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 12.1. Key Highlights
- 12.2. Pricing Analysis
- 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. South Africa
- 12.3.3. Northern Africa
- 12.3.4. Rest of MEA
- 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 12.4.1. Odactra
- 12.4.2. Grastek
- 12.4.3. Ragwitek
- 12.4.4. Oralair
- 12.4.5. Actair
- 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 12.5.1. Allergic Rhinitis
- 12.5.2. Allergic Asthma
- 12.5.3. Food Allergy
- 12.5.4. Atopic Dermatitis
- 12.5.5. Others
- 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 12.6.1. Pollen
- 12.6.2. House Dust Mites
- 12.6.3. Mold
- 12.6.4. Animal Dander
- 12.6.5. Bee Venom
- 12.6.6. Cockroaches/Insects
- 12.6.7. Others
- 12.7. Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 12.7.1. Institutional Sales
- 12.7.2. Retail Sales
13. Competition Landscape
- 13.1. Market Share Analysis, 2025
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles
- 13.3.1. ALK Abello
- 13.3.1.1. Company Overview
- 13.3.1.2. Product Portfolio/Offerings
- 13.3.1.3. Key Financials
- 13.3.1.4. SWOT Analysis
- 13.3.1.5. Company Strategy and Key Developments
- 13.3.2. Stallergenes Greer
- 13.3.3. Allergy Therapeutics
- 13.3.4. Aimmune Therapeutics
- 13.3.5. Merck
- 13.3.6. Biomay AG
- 13.3.7. HAL Allergy Group
- 13.3.8. DBV Technologies
- 13.3.9. Merck KgaA
- 13.3.10. WOLWpharma
- 13.3.1. ALK Abello
14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
